Lv1
36 积分 2025-03-31 加入
Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
2天前
已完结
Regulatory B cells in autoimmunity: developments and controversies
13天前
已完结
Atopic dermatitis relapse after treatment discontinuation and predictive factors for relapse: JAK1 inhibitors versus dupilumab
4个月前
已完结
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study
4个月前
已完结
Humoral determinants of checkpoint immunotherapy
5个月前
已完结
The dual role of IL-2 in systemic lupus erythematosus: balancing pro-inflammatory and anti-inflammatory effects
7个月前
已完结
The Lasting Impact of IL-2: Approaching 50 Years of Advancing Immune Tolerance, Cancer Immunotherapies, and Autoimmune Diseases
7个月前
已完结
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
8个月前
已完结
An agonist TIGIT mab suppresses regulatory T cell activity via an IL-2-mediated mechanism
10个月前
已关闭
CAR T-cell therapy in autoimmune diseases
10个月前
已完结
皖公网安备34019202002308
